Impact of Body Weight on the Immediate Health of the Pediatric Population
NCT ID: NCT00267631
Last Updated: 2013-08-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5392 participants
OBSERVATIONAL
2005-04-30
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methodology: As part of routine patient care, we measured length in addition to weight of patients 2 years to 18 years of age presenting to the pediatric emergency department. A report was run monthly to calculate the BMI of all patients for whom data is available. The data were plotted on the year 2000 gender based BMI for age percentile growth charts from CDC. A retrospective electronic chart review was conducted for patients At Risk body weight (BMI ≥ 85%), and were compared to "control" or healthy (BMI of 25 - 75 %) group for six groups of final ED diagnoses of infectious diseases.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Obesity is a public health issue in the United States. Obesity amongst children is rising at an alarming rate. Thirty percent of US children aged 6 to 19 are over weight and 15 % are obese1. It is estimated that over 18 million US children are over weight. The long-term impact of childhood obesity on such diseases as Diabetes, Asthmaand Hypertension, is well studied. The effects of childhood obesity on the current health status of the pediatric population have not been studied.
B. Methodology:
As part of routine patient care, we measured length in addition to weight of patients 2 years to 18 years of age presenting to the pediatric emergency department. A report was run monthly to calculate the BMI of all patients for whom data is available. The data were plotted on the year 2000 gender based BMI for age percentile growth charts from CDC. A retrospective electronic chart review was conducted for patients At Risk body weight (BMI ≥ 85%), and were compared to "control" or healthy (BMI of 25 - 75 %) group for six groups of final ED diagnoses of infectious disease (ID). Data were entered and analyzed via SPSS 14.0 for Windows 2000 software systems.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
At Risk Body Weight
Children with a BMI greater and equal to 85%
No interventions assigned to this group
Normal Body Weight
Children with a BMI of 25 to 75%
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
2 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Antonios Likourezos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonios Likourezos
Research Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Estevan Garcia, MD
Role: PRINCIPAL_INVESTIGATOR
Maimonides Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maimonides Medical Center
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-02-VA10
Identifier Type: -
Identifier Source: org_study_id